Preclinical evaluation demonstrates superior hepatoprotective activity of lipoic acid-conjugated shikonofuran derivatives over bicyclol, suggesting potential as therapeutic leads.
, bearing a lipoic acid moiety, displayed superior activity compared with the positive control bicyclol. This study provides experimental evidence for further investigation of these compounds and the development of hepatoprotective leads.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: